论文部分内容阅读
应用抗白细胞单克隆抗体L_3B_(12)对69例淋巴瘤(包括淋巴结非何杰金淋巴瘤、何杰金淋巴瘤、皮肤淋巴瘤、鼻咽淋巴瘤、胃淋巴瘤、子宫颈及睾丸淋巴瘤等)和277例非淋巴系统肿瘤(包括乳腺癌、胃癌、肠癌、肺癌、肝癌、宫颈癌、卵巢癌、甲状腺癌和成骨肉瘤、滑膜肉瘤、脂肪肉瘤、平滑肌肉瘤、横纹肌肉瘤、尤文瘤等)进行了标记。对淋巴瘤的标记均为阳性,对非淋巴系统肿瘤的标记均为阴性。实验结果提示L_aB_(12)在临床病理学上能有效地应用于对恶性淋巴瘤与非淋巴系统肿瘤的鉴别诊断。
69 cases of lymphoma (including lymph node non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, cutaneous lymphoma, nasopharyngeal lymphoma, gastric lymphoma, cervical and testicular lymphoma, anti-leukemia monoclonal antibody L_3B_ (12) ) And 277 non-lymphoid tumors (including breast, stomach, colon, lung, liver, cervix, ovary, thyroid and osteosarcoma, synovial sarcoma, liposarcoma, leiomyosarcoma, rhabdomyosarcoma, Tumor, etc.) were marked. Positive for lymphoma and negative for non-lymphoid tumors. The experimental results suggest that L_aB_ (12) can be effectively applied in the differential diagnosis of malignant and non-lymphoid tumors in clinicopathology.